Leidos (NYSE:LDOS) Price Target Lowered to $197.00 at Wells Fargo & Company

Leidos (NYSE:LDOS) had its price target cut by analysts at Wells Fargo & Company from $199.00 to $197.00 in a research report issued to clients and investors on Wednesday,Benzinga reports. The firm presently has an “overweight” rating on the aerospace company’s stock. Wells Fargo & Company‘s price target suggests a potential upside of 43.41% from the company’s previous close.

A number of other analysts have also recently commented on the stock. Citigroup boosted their target price on shares of Leidos from $194.00 to $220.00 and gave the company a “buy” rating in a report on Wednesday, October 30th. Cantor Fitzgerald started coverage on shares of Leidos in a report on Friday, February 7th. They set an “overweight” rating and a $185.00 target price for the company. Barclays increased their target price on Leidos from $165.00 to $210.00 and gave the stock an “overweight” rating in a research note on Monday, November 4th. UBS Group initiated coverage on shares of Leidos in a report on Monday, December 2nd. They issued a “neutral” rating and a $182.00 target price for the company. Finally, Royal Bank of Canada increased their price target on shares of Leidos from $145.00 to $180.00 and gave the company a “sector perform” rating in a report on Wednesday, October 30th. Five investment analysts have rated the stock with a hold rating, nine have assigned a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat.com, Leidos presently has a consensus rating of “Moderate Buy” and a consensus price target of $179.33.

Leidos Stock Down 3.8 %

NYSE LDOS opened at $137.37 on Wednesday. Leidos has a 1 year low of $113.67 and a 1 year high of $202.90. The company has a debt-to-equity ratio of 0.87, a current ratio of 1.23 and a quick ratio of 1.15. The business’s 50-day moving average is $149.31 and its 200 day moving average is $157.71. The stock has a market capitalization of $18.33 billion, a PE ratio of 15.65, a PEG ratio of 0.92 and a beta of 0.66.

Leidos (NYSE:LDOS) last issued its quarterly earnings data on Tuesday, February 11th. The aerospace company reported $2.37 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.24 by $0.13. Leidos had a net margin of 7.37% and a return on equity of 30.31%. Sell-side analysts forecast that Leidos will post 10.03 earnings per share for the current year.

Insider Buying and Selling

In other news, Director Noel B. Geer purchased 2,000 shares of the company’s stock in a transaction on Wednesday, November 20th. The stock was acquired at an average cost of $161.13 per share, for a total transaction of $322,260.00. Following the completion of the transaction, the director now directly owns 2,000 shares in the company, valued at $322,260. This trade represents a ∞ increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available through the SEC website. 0.96% of the stock is currently owned by insiders.

Institutional Trading of Leidos

Institutional investors and hedge funds have recently modified their holdings of the company. Rakuten Securities Inc. boosted its stake in Leidos by 1,460.0% in the 3rd quarter. Rakuten Securities Inc. now owns 156 shares of the aerospace company’s stock worth $25,000 after purchasing an additional 146 shares during the period. Duncker Streett & Co. Inc. purchased a new position in shares of Leidos in the fourth quarter worth $27,000. Ashton Thomas Securities LLC bought a new position in shares of Leidos during the third quarter worth $29,000. Berbice Capital Management LLC purchased a new position in Leidos during the fourth quarter valued at $29,000. Finally, Northwest Investment Counselors LLC purchased a new position in Leidos during the third quarter valued at $30,000. 76.12% of the stock is currently owned by institutional investors.

About Leidos

Leidos Holdings, Inc, together with its subsidiaries, provides services and solutions in the defense, intelligence, civil, and health markets in the United States and internationally. The company operates through Defense Solutions, Civil, and Health segments. The Defense Solutions segment offers national security solutions and systems for air, land, sea, space, and cyberspace for the U.S.